We are live on !
Find out more
PFM Health Sciences Portfolio holdings
AUM
$1B
Turnover
54.4%
1-Year Est. Return
77.91%
This Fund
S&P 500
This Quarter Est. Return
+4.1%
1 Year Est. Return
+77.91%
3 Year Est. Return
+264.51%
5 Year Est. Return
+347.39%
10 Year Est. Return
+2,853.52%
AUM
$1B
AUM Growth
-$163M
(-14%)
Cap. Flow
-$192M
Cap. Flow % of AUM
Cap. Flow %
-19.11%
Top 10 Holdings %
Top 10 Hldgs %
34.22%
Holding
125
New
27
Increased
26
Reduced
29
Closed
41
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
1
year
Top 20 Avg Time Held
Equity + Options
0.9
years
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$24.6M |
| 2 |
CONMED
CNMD
|
+$14.9M |
| 3 |
Zimmer Biomet
ZBH
|
+$14.7M |
| 4 |
Glaukos
GKOS
|
+$13.4M |
| 5 |
Supernus
SUPN
|
+$12.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Penumbra
PEN
|
+$19M |
| 2 |
Stryker
SYK
|
+$17.8M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$17.7M |
| 4 |
Mettler-Toledo International
MTD
|
+$17M |
| 5 |
Humana
HUM
|
+$16.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.51% |
| 2 | Miscellaneous | 9.49% |
Similar funds
KL
IAM
PFM Health Sciences's Q3 2026 Portfolio in Review
As of Q3 2026, PFM Health Sciences held 125 positions worth $1B, down 14% from $1.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
PFM Health Sciences withdrew a net $192M in Q3 2026, closing 41 positions and reducing 29 holdings. Its most notable exit was Penumbra, an estimated $19M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 99% a quarter earlier, followed by Miscellaneous.
Against the trend, PFM Health Sciences opened a new position in State Street SPDR S&P 500 ETF Trust worth $24.7M.
- PFM Health Sciences's largest Q3 2026 buy was State Street SPDR S&P 500 ETF Trust: 32,421 shares worth $24.7M.
- PFM Health Sciences added most to Supernus in Q3 2026, an estimated $12.9M increase.
- PFM Health Sciences's biggest Q3 2026 reduction was Jazz Pharmaceuticals, cutting an estimated $17.7M.
- PFM Health Sciences fully exited Penumbra in Q3 2026, selling an estimated $19M.
- PFM Health Sciences's ten largest holdings make up 34% of its $1B portfolio in Q3 2026.
- PFM Health Sciences opened 27 new positions and closed 41 in Q3 2026.
- PFM Health Sciences's portfolio value fell 14% quarter-over-quarter to $1B.
Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.